Condition

Immunogenicity clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Immunogenicity clinical trials that are recruiting, at sites in 2 countries (most in South Korea (2), Ethiopia (1)). By phase: Phase 3 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Immunogenicity clinical trials

StudyPhaseWhereStatusRegistered
Influenza Vaccine Immunogenicity in Older Adults with Repeated Vaccination Phase 4 Seoul Recruiting Sep 24, 2026
Immunogenicity screening of Leishmania vaccine candidate antigens in Ethiopian patients — Addis Ababa and 1 other locations Recruiting Aug 24, 2026
Flu vaccine strategies for adults with blood cancers Phase 3 Seoul Recruiting Mar 20, 2026

All recruiting trials (3)

Related topics

Hematologic NeoplasmsImmunosenescenceInfluenzaInfluenza VaccinationLeishmaniasisLeishmaniasis, CutaneousLeishmaniasis, VisceralOlder Adults (65 Years and Older)

Quick answers

How many Immunogenicity clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in South Korea (2 trials), Ethiopia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.